Meeting News

Genetic testing may improve patient screening for refractive surgery

January 27, 2020
KOLOA, Hawaii — Genetic testing can identify loci and genes for inherited eye diseases and can help improve screening processes to identify…

Meeting News

Prevention ‘best treatment’ for zoster ophthalmicus

January 23, 2020
KOLOA, Hawaii — The ocular manifestations of herpes zoster involve a wide range of corneal disease with the estimated worldwide cost for…

Meeting News

Unregulated cosmetics contribute to ocular surface disease

January 23, 2020
KOLOA, Hawaii — A person who uses beauty products containing prostaglandins around their eyes and eyelashes may be spending a lot of money to…

Meeting NewsVideo

VIDEO: Leyngold touts corneal neurotization for neurotrophic keratopathy

January 23, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Ilya M. Leyngold, MD, discusses how his team has been using a corneal neurotization technique to restore…

Aldeyra initiates phase 3 reproxalap trial

January 22, 2020
The first patient has been enrolled in a phase 3 trial of Aldeyra Therapeutics’ allergic conjunctivitis treatment candidate reproxalap…

Meeting News

Presence of edema guides treatment of Fuchs' dystrophy and cataract

January 21, 2020
KOLOA, Hawaii — In a patient with Fuchs’ dystrophy and cataract, PK is the cornea technique of the past and endothelial keratoplasty is…

Meeting NewsVideo

VIDEO: Holland Foundation for Sight Restoration set to launch at World Cornea Day

January 20, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Edward J. Holland, MD, and Bindu Manne, director of market development at Ocular Therapeutix, discuss…

Meeting NewsVideo

VIDEO: Dry eye disease treatment starts with education and evaluation

January 19, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Mitchell A. Jackson, MD, founder and CEO of Jacksoneye in Lake Villa, Illinois, says that dry eye…

Meeting NewsVideo

VIDEO: Klarity-C study shows improvements in dry eye scores

January 18, 2020
KOLOA, Hawaii — At Hawaiian Eye 2020, Cynthia A. Matossian, MD, founder of Matossian Eye Associates, discusses her preliminary look at 3-month…

Kala completes enrollment in STRIDE 3 trial

January 17, 2020
Kala Pharmaceuticals has completed enrollment in the STRIDE 3 trial for KPI-121 0.25%, a treatment for temporary dry eye relief, according to a press…

Meeting News

Glaukos leverages acquisitions to enter new ophthalmology spaces

January 16, 2020
With recent acquisitions, Glaukos now has multiple products in development that expand its reach outside of the glaucoma space and into more…

Meeting News

Oyster Point’s dry eye nasal spray meets phase 2 endpoints

January 15, 2020
Oyster Point Pharma’s nasal spray treatment for dry eye disease has met its primary endpoints in the phase 2 MYSTIC trial, CEO and President…

CustomFlex artificial iris receives transitional pass-through payment status

January 15, 2020
The CustomFlex artificial iris was granted transitional pass-through payment status from CMS, effective Jan. 1, 2020. The artificial iris from VEO…

In the JournalsPerspective

Asymmetric keratoconus correction may improve visual acuity, refractive outcomes

January 13, 2020
A progressive thickness intrastromal corneal ring segment may help improve visual acuity and refractive outcomes in patients with asymmetric…

Allysta doses first patient in phase 1/2a dry eye trial

January 8, 2020
The first patient has been dosed in a phase 1/2a trial of ALY688, a dry eye treatment candidate, Allysta Pharmaceuticals announced in a press…


What is your treatment process when a lifesaving therapy results in worsening ocular symptoms?

Ocular Surgery News U.S. Edition, January 25, 2020
As a retina specialist, my busy private practice sees a wide spectrum of the patient population. We have a significant number of patients on…

The Dry Eye

The New Year’s resolutions of a dry eye doc

Ocular Surgery News U.S. Edition, January 25, 2020
Darrell E. White, MD
It is almost the end of January when you are reading this, but I wrote it at the end of a Thanksgiving weekend when I had a bit too much time on my…

Cover Story

Systemic drugs and their ocular symptoms can complicate treatment

Ocular Surgery News U.S. Edition, January 25, 2020
Drugs that treat systemic diseases can be lifesaving, but when these drugs lead to poor ocular health or vision, the treatment paradigms can be…


In-office testing, off-label therapy may be best approach for EKC

Ocular Surgery News U.S. Edition, January 25, 2020
Alice T. Epitropoulos, MD, FACS; Priyanka Sood, MD
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to…

Lindstrom's Perspective

Close monitoring needed to avoid drug-induced ocular side effects

Ocular Surgery News U.S. Edition, January 25, 2020
Richard L. Lindstrom, MD
Drug-induced ocular side effects are common in every ophthalmologist’s practice. When we review our senior patients’ lists of medicines…